Clinical Trial Update: The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and effectiveness of Interferon Alfa-2B plus Didanosine in Kaposi's sarcoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Kaposi Sarcoma

Drugs mentioned

• Didanosine (didanosine)
• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Sarcoma, Kaposi, HIV Infections | Phase 2 | Status: COMPLETED